AU2019304781B2 - Fatty acid derivative labeled with positron-emitting radionuclide - Google Patents

Fatty acid derivative labeled with positron-emitting radionuclide Download PDF

Info

Publication number
AU2019304781B2
AU2019304781B2 AU2019304781A AU2019304781A AU2019304781B2 AU 2019304781 B2 AU2019304781 B2 AU 2019304781B2 AU 2019304781 A AU2019304781 A AU 2019304781A AU 2019304781 A AU2019304781 A AU 2019304781A AU 2019304781 B2 AU2019304781 B2 AU 2019304781B2
Authority
AU
Australia
Prior art keywords
fatty acid
salt
acid derivative
compound
labeled fatty
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2019304781A
Other languages
English (en)
Other versions
AU2019304781A1 (en
Inventor
Yuji Fujita
Hiroshi FUSHIKI
Yoshihiro Murakami
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astellas Pharma Inc
Original Assignee
Astellas Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astellas Pharma Inc filed Critical Astellas Pharma Inc
Publication of AU2019304781A1 publication Critical patent/AU2019304781A1/en
Application granted granted Critical
Publication of AU2019304781B2 publication Critical patent/AU2019304781B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0402—Organic compounds carboxylic acid carriers, fatty acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/54—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and unsaturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/001—Acyclic or carbocyclic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/52—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01T—MEASUREMENT OF NUCLEAR OR X-RADIATION
    • G01T1/00—Measuring X-radiation, gamma radiation, corpuscular radiation, or cosmic radiation
    • G01T1/16—Measuring radiation intensity
    • G01T1/161—Applications in the field of nuclear medicine, e.g. in vivo counting
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/05—Isotopically modified compounds, e.g. labelled

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Medical Informatics (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Physics & Mathematics (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Molecular Biology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nuclear Medicine (AREA)
AU2019304781A 2018-07-20 2019-07-19 Fatty acid derivative labeled with positron-emitting radionuclide Active AU2019304781B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2018-136483 2018-07-20
JP2018136483 2018-07-20
PCT/JP2019/028380 WO2020017620A1 (ja) 2018-07-20 2019-07-19 陽電子放出核種で標識された脂肪酸誘導体

Publications (2)

Publication Number Publication Date
AU2019304781A1 AU2019304781A1 (en) 2021-02-11
AU2019304781B2 true AU2019304781B2 (en) 2023-12-21

Family

ID=69164918

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2019304781A Active AU2019304781B2 (en) 2018-07-20 2019-07-19 Fatty acid derivative labeled with positron-emitting radionuclide

Country Status (9)

Country Link
US (1) US12029797B2 (https=)
EP (1) EP3825302B1 (https=)
JP (1) JP7375755B2 (https=)
KR (1) KR102718221B1 (https=)
CN (1) CN112638868B (https=)
AU (1) AU2019304781B2 (https=)
CA (1) CA3106903A1 (https=)
ES (1) ES3009015T3 (https=)
WO (1) WO2020017620A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES3009015T3 (en) 2018-07-20 2025-03-25 Astellas Pharma Inc Fatty acid derivative labeled with positron-emitting radionuclide
US20230065079A1 (en) * 2020-01-17 2023-03-02 Astellas Pharma Inc. Fatty acid derivative labeled with positron-emitting radionuclide

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000063216A1 (en) * 1999-04-19 2000-10-26 Duke University F-18-labeled thia fatty acids and methods of making and using the same

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2828623C2 (de) 1978-06-29 1983-11-17 Kernforschungsanlage Jülich GmbH, 5170 Jülich Mit radioaktivem Flour markierte C↓1↓↓6↓-bis C↓1↓↓8↓- Fettsäuren, ein Verfahren zu ihrer Herstellung sowie deren Verwendung
CA2522737C (en) * 2003-04-17 2017-06-06 The General Hospital Corporation Method for monitoring blood flow and metabolic uptake in tissue with radiolabeled alkanoic acid
CN1217924C (zh) 2003-10-17 2005-09-07 江苏省原子医学研究所 一种氟标记脂肪酸心肌代谢显像剂14(r,s)－氟[18f]－6－硫十七烷酸的纯化方法
CA2760334A1 (en) 2009-05-04 2010-11-11 Washington University Pet radiotracers for imaging fatty acid metabolism and storage
WO2014179341A1 (en) 2013-04-29 2014-11-06 Matinas Biopharma, Inc. Treatment with omega-3 fatty acid compositions
WO2015023631A2 (en) 2013-08-12 2015-02-19 Carolyn Anderson Fatty acid analogs and their use
CN105523977B (zh) 2016-02-04 2017-05-24 河南中医学院 [11c]‑巯甲基脂肪酸的制备方法与应用
ES3009015T3 (en) 2018-07-20 2025-03-25 Astellas Pharma Inc Fatty acid derivative labeled with positron-emitting radionuclide
US20230065079A1 (en) 2020-01-17 2023-03-02 Astellas Pharma Inc. Fatty acid derivative labeled with positron-emitting radionuclide

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000063216A1 (en) * 1999-04-19 2000-10-26 Duke University F-18-labeled thia fatty acids and methods of making and using the same

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
CAI,Z. ET AL.: "Synthesis and preliminary evaluation of an 18F-labeled oleic acid analog for PET imaging of fatty acid uptake and metabolism", NUCLEAR MEDICINE AND BIOLOGY, vol. 43, 2016, pp 108 - 115, DOI: 10.1016/j.nucmedbio.2015.08.005 *
DEGRADO T R ET AL: "Synthesis and preliminary evaluation of ^1^8F-labeled 4-thia palmitate as a PET tracer of myocardial fatty acid oxidation", NUCL. MED. BIOL, ELSEVIER, NY, US, vol. 27, no. 3, 1 April 2000 (2000-04-01), pages 221 - 231. *
DEGRADO, T. R. ET AL.: "Synthesis and preliminary evaluation of 18-18F-fluoro-4-thia-oleate as a PET probe of fatty acid oxidation", JOURNAL OF NUCLEAR MEDICINE, vol. 51, no. 8, 2010, pages 1310 - 1317, XP055681541 *
PANDEY, M. K. ET AL.: "Structure Dependence of Long-Chain [18F]Fluorothia Fatty Acids as Myocardial Fatty Acid Oxidation Probes", JOURNAL OF MEDICINAL CHEMISTRY, vol. 55, no. 23, 2012, pages 10674 - 10684, XP055681542 *

Also Published As

Publication number Publication date
US20210338845A1 (en) 2021-11-04
CN112638868B (zh) 2023-06-20
KR102718221B1 (ko) 2024-10-15
US12029797B2 (en) 2024-07-09
ES3009015T3 (en) 2025-03-25
EP3825302A1 (en) 2021-05-26
CN112638868A (zh) 2021-04-09
WO2020017620A1 (ja) 2020-01-23
EP3825302B1 (en) 2025-01-08
AU2019304781A1 (en) 2021-02-11
KR20210032392A (ko) 2021-03-24
CA3106903A1 (en) 2020-01-23
JP7375755B2 (ja) 2023-11-08
EP3825302A4 (en) 2022-05-04
JPWO2020017620A1 (ja) 2021-08-02

Similar Documents

Publication Publication Date Title
JP7209897B2 (ja) Ｃｒｂｎタンパク質モジュレーターとしての二環式化合物
AU2019304781B2 (en) Fatty acid derivative labeled with positron-emitting radionuclide
CN112955453A (zh) 作为选择性Trk抑制剂的吡唑并嘧啶衍生物
HUT62560A (en) Process for producing 24-oxa derivatives belonging to vitamin d series and pharmaceutical compositions comprising same as active ingredient
CN102741264A (zh) 前列腺特异性膜抗原抑制剂
EP4095126A1 (en) Fatty acid derivative labeled by positron-emitting nuclide
JP6048958B2 (ja) 副腎疾患の画像診断剤
JP3923090B2 (ja) ビタミンｄ３誘導体およびその製造法
WO2021219135A1 (zh) 一种肌醇衍生物及其用途
FR3068695B1 (fr) Composes utiles comme agent d'imagerie de l'hypoxie
WO2023016528A1 (zh) 一类苯并吗啉类化合物及其制备方法和用途
EP2744776A1 (en) New ligands for targeting of s1p receptors for in vivo imaging and treatment of diseases
US6362352B1 (en) F18-labeled thia fatty acids and methods of making and using the same
WO2020200153A1 (zh) 作为sglt1抑制剂的葡糖苷类衍生物及其应用
HUP0102710A2 (hu) Új eljárás prosztaglandinvegyületek előállítására
TW202442243A (zh) 用於製備寡核苷酸類似物或其鹽的中間體及其製備方法
HK40083691A (en) Inositol derivative and use thereof
JP2019085344A (ja) 放射性フッ素標識化合物

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)